Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants

Clicks: 241
ID: 274656
2006
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
A 2.7% prevalence of macrolide resistance in 1,657 Norwegian clinical Streptococcus pyogenes isolates was primarily due to erm(TR) (59%) and mef(A) (20%). Four clonal complexes comprised 75% of the strains. Macrolide resistance in S. pyogenes in Norway is imported as resistant strains or locally sel …
Reference Key
p2006antimicrobialmacrolide-resistant Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Littauer P;Caugant DA;Sangvik M;Høiby EA;Sundsfjord A;Simonsen GS;;
Journal Antimicrobial agents and chemotherapy
Year 2006
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/16641473
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE genetic pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Bacterial DNA Genes Sequence Analysis drug resistance streptococcus pyogenes / isolation & purification streptococcal infections / epidemiology streptococcal infections / microbiology streptococcus pyogenes / drug effects* prevalence selection streptococcal infections / drug therapy norway / epidemiology bacterial / genetics* alleles streptococcus pyogenes / genetics d a caugant pmid:16641473 pmc1472204 doi:10.1128/aac.50.5.1896-1899.2006 p littauer g s simonsen macrolides / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.